Transaction

Investment in Matcher Technologies Ltd from ReproTech LLC

Transaction

Investment in Matcher Technologies Ltd from ReproTech LLC

Sell-side

Undisclosed

Role

Adviser to Matcher Technologies Ltd on its investment from ReproTech LLC

Sector

Tech & Tech Services
Healthcare

Region

UK

We have advised IMT Matcher, a global leader in fertility technology, on its investment from ReproTech, a leading provider of reproductive cryostorage and cryostorage technology solutions in the US. 

IMT Matcher is renowned for developing the world’s first electronic witnessing system over 20 years ago. Its specialised e-witnessing and traceability software solution protects against the many and varied risks of error in IVF treatment and streamlines fertility centre processes. Over the past two decades, the company has played a pivotal role in shaping industry best practices and educating the market. 

Delaware-based ReproTech is a provider of cryostorage technology solutions, off-site storage and logistics services. The company partners with fertility clinics, hospital systems, donor banks, and andrology laboratories across North America to offer secure, state-of-the-art storage for sperm, oocytes, embryos, stem cells, oncofertility-specific tissues, and other reproductive tissues—ensuring patients have future options for family formation.

This strategic investment strengthens ReproTech’s leadership in cryostorage by enhancing its existing traceability solutions. The integration of IMT Matcher’s expertise and technology with ReproTech’s existing suite of cryostorage and safety-focused products marks a major step towards the first comprehensive platform for patients and clinics to digitally document every step of the IVF process while providing the safest storage solutions on the market.

IMT Matcher, founded in 2005, has built a strong reputation for expertise in its niche through the capability and quality of its product, continual innovation, and excellent customer service. Following the investment, Matcher’s operations will continue from its UK headquarters uninterrupted for end users and the existing distributor network.

More about the process

We worked closely with the management team from start to finish, guiding them through all stages of the process. We facilitated the buyer outreach across Europe and the US running a streamlined and competitive process which ultimately led to IMT Matcher finding the right partner in ReproTech. Our hands-on approach provided both comfort to all team members involved as well as efficient process management to realise all shareholders' objectives.

IMT Matcher

Clearwater’s deep understanding of the fertility tech landscape, their ability to engage with strategic US acquirers, and their collaborative approach were instrumental in achieving this outcome.
ReproTech’s reputation as a trusted storage solutions partner—with 35 years of experience—and their dedication to advancing traceability in fertility care make them an ideal partner. Together, we can drive innovation and enhance our service offerings in both domestic and international markets.

George Heywood, CEO, Matcher Technologies Ltd
IMT Matcher

We are thrilled to partner with IMT Matcher to continue our combined journey of providing the highest quality, safest, and most compliant products for our clinic partners. Their team, technology, mission, and values align perfectly with our commitment to exceptional service, advanced technologies, and stringent compliance standards.

Brad Senstra, CEO, ReproTech

This was a highly strategic transaction, leveraging our US relationships to deliver an outstanding result for IMT Matcher’s shareholders. We recognised the unique value IMT Matcher offered to a select group of buyers and ran a focused process to ensure that value was fully realised.

Ed Gale, Partner, Clearwater

The fertility sector is experiencing long-term growth, driven by rising patient demand and supported by ongoing consolidation among clinic groups. The evolution of this landscape has created the ideal conditions for greater professionalisation across the supply chain. IMT Matcher exemplifies this trend—its technology addresses a critical need for traceability and safety, which is paramount for clinicians and hopeful parents alike.

Krushi Hindocha, Director, Clearwater

Advisers

Transactions